168.4K(top 1%)
articles
4.4M(top 1%)
citations
41,527(top 1%)
★★ articles
1,707(top 1%)
★★★ articles
2.4(top 22%)
Avg IF
503(top 1%)
H-Index
820(top 1%)
G-Index
13,140
journals

Most Cited Articles of University of Sydney in 2012

TitleJournalYearCitations
Partitionfinder: combined selection of partitioning schemes and substitution models for phylogenetic analysesMolecular Biology and Evolution20124.1K
Guidelines for the use and interpretation of assays for monitoring autophagyAutophagy20122.8K
Global prevalence and major risk factors of diabetic retinopathyDiabetes Care20122.5K
Correlates of physical activity: why are some people physically active and others not?Lancet, The20122.2K
A systematic review of the global prevalence of low back painArthritis and Rheumatism20121.4K
Interventions for preventing falls in older people living in the communityThe Cochrane Library20121.2K
Audit and feedback: effects on professional practice and healthcare outcomesThe Cochrane Library20121.2K
Enhancing transparency in reporting the synthesis of qualitative research: ENTREQBMC Medical Research Methodology20121.2K
Global continental and ocean basin reconstructions since 200MaEarth-Science Reviews20121.2K
Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreementJournal of Clinical Epidemiology20121.1K
A systematic survey of loss-of-function variants in human protein-coding genesScience2012880
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fractureNature Genetics2012866
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional studyLancet Neurology, The2012830
Deformation twinning in nanocrystalline materialsProgress in Materials Science2012817
Wide-band negative permeability of nonlinear metamaterialsScientific Reports2012781
Towards high-power mid-infrared emission from a fibre laserNature Photonics2012741
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trialLancet Oncology, The2012708
International trade drives biodiversity threats in developing nationsNature2012686
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomesJournal of Clinical Epidemiology2012661
Risk prediction models: II. External validation, model updating, and impact assessmentHeart2012609
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanomaCell2012595
A single-atom transistorNature Nanotechnology2012587
Mapping the structure of the world economyEnvironmental Science & Technology2012575
Engineered two-dimensional Ising interactions in a trapped-ion quantum simulator with hundreds of spinsNature2012566
Seed germination and vigorAnnual Review of Plant Biology2012565